Danala Gopichandh, Thai Theresa, Gunderson Camille C, Moxley Katherine M, Moore Kathleen, Mannel Robert S, Liu Hong, Zheng Bin, Qiu Yuchen
School of Electrical and Computer Engineering, University of Oklahoma, 101 David L. Boren Blvd, Norman, OK 73019.
Health Science Center of University of Oklahoma, Oklahoma City, Oklahoma.
Acad Radiol. 2017 Oct;24(10):1233-1239. doi: 10.1016/j.acra.2017.04.014. Epub 2017 May 26.
The study aimed to investigate the role of applying quantitative image features computed from computed tomography (CT) images for early prediction of tumor response to chemotherapy in the clinical trials for treating ovarian cancer patients.
A dataset involving 91 patients was retrospectively assembled. Each patient had two sets of pre- and post-therapy CT images. A computer-aided detection scheme was applied to segment metastatic tumors previously tracked by radiologists on CT images and computed image features. Two initial feature pools were built using image features computed from pre-therapy CT images only and image feature difference computed from both pre- and post-therapy images. A feature selection method was applied to select optimal features, and an equal-weighted fusion method was used to generate a new quantitative imaging marker from each pool to predict 6-month progression-free survival. The prediction accuracy between quantitative imaging markers and the Response Evaluation Criteria in Solid Tumors (RECIST) criteria was also compared.
The highest areas under the receiver operating characteristic curve are 0.684 ± 0.056 and 0.771 ± 0.050 when using a single image feature computed from pre-therapy CT images and feature difference computed from pre- and post-therapy CT images, respectively. Using two corresponding fusion-based image markers, the areas under the receiver operating characteristic curve significantly increased to 0.810 ± 0.045 and 0.829 ± 0.043 (P < 0.05), respectively. Overall prediction accuracy levels are 71.4%, 80.2%, and 74.7% when using two imaging markers and RECIST, respectively.
This study demonstrated the feasibility of predicting patients' response to chemotherapy using quantitative imaging markers computed from pre-therapy CT images. However, using image feature difference computed between pre- and post-therapy CT images yielded higher prediction accuracy.
本研究旨在探讨在卵巢癌患者治疗的临床试验中,应用从计算机断层扫描(CT)图像计算得出的定量图像特征对肿瘤化疗反应进行早期预测的作用。
回顾性收集了一个包含91例患者的数据集。每位患者有两组治疗前和治疗后的CT图像。应用计算机辅助检测方案对放射科医生先前在CT图像上追踪的转移瘤进行分割并计算图像特征。使用仅从治疗前CT图像计算的图像特征和从治疗前及治疗后图像计算的图像特征差异构建了两个初始特征池。应用特征选择方法选择最佳特征,并使用等权重融合方法从每个池中生成一个新的定量成像标志物,以预测6个月无进展生存期。还比较了定量成像标志物与实体瘤疗效评价标准(RECIST)标准之间的预测准确性。
使用从治疗前CT图像计算的单个图像特征和从治疗前及治疗后CT图像计算的特征差异时,受试者操作特征曲线下的最高面积分别为0.684±0.056和0.771±0.050。使用两个相应的基于融合的图像标志物时,受试者操作特征曲线下的面积分别显著增加至0.810±0.045和0.829±0.043(P<0.05)。使用两个成像标志物和RECIST时,总体预测准确率分别为71.4%、80.2%和74.7%。
本研究证明了使用从治疗前CT图像计算的定量成像标志物预测患者化疗反应的可行性。然而,使用治疗前和治疗后CT图像之间计算的图像特征差异可产生更高的预测准确性。